BlueMtec

Seongnam-si, South Korea Founded: 2015 • Age: 11 yrs
Provider of prescription medicine AI platform for medical supplies and consumables in the healthcare industry
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 6 Brand Intelligence

About BlueMtec

BlueMtec is a company based in Seongnam-si (South Korea) founded in 2015. BlueMtec operates in a competitive market with competitors including AmerisourceBergen, Ahn-Gook Pharmaceutical, Taejeon Group, Blue Farm Korea and Nexus Pharma, among others.

  • Headquarter Seongnam-si, South Korea
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of BlueMtec

BlueMtec is a publicly listed company on the KRX with ticker symbol 439580 in South Korea, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: KRX · Ticker: 439580 · Sector: Distribution services · South Korea

Funding Insights of BlueMtec

Investors in BlueMtec

BlueMtec has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include New Paradigm Investment.

All
Venture Fund
Investor Description Founded Year Domain Location
-
Locked Locked Locked
Premium access

Investor details for BlueMtec

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BlueMtec

Investments
Premium access

Investment portfolio details for BlueMtec

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - BlueMtec

Premium access

Detailed financials for BlueMtec

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Bluemtec Comparisons

BlueMtec Primary company
Description
Provider of prescription medicine AI platform for medical su...
Location
Seongnam-si, South Korea
Founded Year
2015
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for BlueMtec

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of BlueMtec

BlueMtec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Ahn-Gook Pharmaceutical, Taejeon Group, Blue Farm Korea and Nexus Pharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical distribution and supply chain services are provided globally.
Locked Locked Locked
Pharmaceutical products
Locked Locked Locked
Distributes a variety of pharmaceutical drugs.
Locked Locked Locked
Online platform for purchasing pharmaceuticals and medical supplies for hospitals.
Locked Locked Locked
Manufactures pharmaceuticals, cosmeceuticals, skincare, and distributes globally to partners and clinics.
Locked Locked Locked
Operates an online shop specializing in medical products for professionals.
Premium access

Detailed competitors of BlueMtec

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Bluemtec

Blue M -Tech invests in Medis Taff
Venturesquare2 years ago
Premium access

Complete news archive for BlueMtec

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BlueMtec

BlueMtec was founded in 2015 and raised its 1st funding round 4 years after it was founded.

BlueMtec is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.

Hyunsoo Kim is the current CEO of BlueMtec.

Provider of prescription medicine AI platform for medical supplies and consumables in the healthcare industry. It also provide services such as online purchasing systems, website developmentmarketing, and B2B platforms.

BlueMtec's top competitors include AmerisourceBergen, Ahn-Gook Pharmaceutical and Taejeon Group.

Yes, BlueMtec is publicly traded on KRX under the ticker symbol 439580.

BlueMtec has 1 investor. Key investors include New Paradigm Investment.

The ticker symbol of BlueMtec is 439580 on KRX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available